 | • レポートコード：QAF27808 • 出版社/出版日：QYResearch / 2021年4月26日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のヌクレアーゼ市場について種類別（DNアーゼ、RNアーゼ）、用途別（学術・研究機関、バイオ医薬品、病院・診断センター、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ヌクレアーゼ市場の概要 ・世界の主要地域別ヌクレアーゼ市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のヌクレアーゼ市場規模2016-2021：種類別（DNアーゼ、RNアーゼ） ・世界のヌクレアーゼ市場予測2012-2027：種類別（DNアーゼ、RNアーゼ） ・世界のヌクレアーゼ市場規模2016-2021：用途別（学術・研究機関、バイオ医薬品、病院・診断センター、その他） ・世界のヌクレアーゼ市場予測2012-2027：用途別（学術・研究機関、バイオ医薬品、病院・診断センター、その他） ・ヌクレアーゼのアメリカ市場規模と予測2016-2021 ・ヌクレアーゼのヨーロッパ市場規模と予測2016-2021 ・ヌクレアーゼの中国市場規模と予測2016-2021 ・ヌクレアーゼの日本市場規模と予測2016-2021 ・ヌクレアーゼの東南アジア市場規模と予測2016-2021 ・ヌクレアーゼのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （New England Biolabs、MercK、Illumina、Thermo Fisher Scientific、Agilent Technologies、Cytiva、Roche、Takara Bio、C-LEcta、Aldevron、Lucigen、Promega Corporation、Qiagen、Amicogen、Codexis、BBI Solution） ・ヌクレアーゼの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ヌクレアーゼの市場動向・機会・課題 ・調査の結論 |
A Nuclease (also archaically known as nucleodepolymerase or polynucleotidase) is an enzyme capable of cleaving the phosphodiester bonds between nucleotides of nucleic acids.
The global well-known brands in Nuclease include New England Biolabs(14.61%), MercK(7.28%), Illumina(6.73%), Thermo Fisher Scientific(4.51%), Agilent Technologies(3.84%), Cytiva(2.99%), Roche(2.94%), Takara Bio(2.47%), C-LEcta(1.90%), Aldevron(1.72%), Lucigen(1.39%), Promega Corporation(1.26%), Qiagen(1.01%), Amicogen(0.60%), Codexis(0.51%), BBI Solution(0.31%) and Others(45.95%).
The application area of Nuclease includes Academic & Research Institutes, Biopharmaceutical, Hospitals & Diagnostic Centers and Other.
In terms of types, Nuclease can be divided into DNases and RNases.
On basis of geography, Nuclease is manufactured in North America, Europe, Japan and Korea.
Market Analysis and Insights: Global Nuclease Market
The global Nuclease market was valued at US$ 493.3 in 2020 and will reach US$ 757.1 million by the end of 2027, growing at a CAGR of 7.4% during 2022-2027.
Global Nuclease Scope and Market Size
The global Nuclease market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nuclease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
DNases
RNases
Segment by Application
Academic & Research Institutes
Biopharmaceutical
Hospitals & Diagnostic Centers
Other
The Nuclease market is analysed and market size information is provided by regions (countries). Segment by Application, the Nuclease market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
New England Biolabs
MercK
Illumina
Thermo Fisher Scientific
Agilent Technologies
Cytiva
Roche
Takara Bio
C-LEcta
Aldevron
Lucigen
Promega Corporation
Qiagen
Amicogen
Codexis
BBI Solution
1 Nuclease Market Overview
1.1 Nuclease Product Scope
1.2 Nuclease Segment by Type
1.2.1 Global Nuclease Sales by Type (2016 & 2021 & 2027)
1.2.2 DNases
1.2.3 RNases
1.3 Nuclease Segment by Application
1.3.1 Global Nuclease Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Academic & Research Institutes
1.3.3 Biopharmaceutical
1.3.4 Hospitals & Diagnostic Centers
1.3.5 Other
1.4 Nuclease Market Estimates and Forecasts (2016-2027)
1.4.1 Global Nuclease Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Nuclease Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Nuclease Price Trends (2016-2027)
2 Nuclease Estimates and Forecasts by Region
2.1 Global Nuclease Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Nuclease Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Nuclease Sales Market Share by Region (2016-2021)
2.2.2 Global Nuclease Revenue Market Share by Region (2016-2021)
2.3 Global Nuclease Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Nuclease Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Nuclease Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Nuclease Estimates and Projections (2016-2027)
2.4.2 Europe Nuclease Estimates and Projections (2016-2027)
2.4.3 China Nuclease Estimates and Projections (2016-2027)
2.4.4 Japan Nuclease Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Nuclease Estimates and Projections (2016-2027)
2.4.6 India Nuclease Estimates and Projections (2016-2027)
3 Global Nuclease Competition Landscape by Players
3.1 Global Top Nuclease Players by Sales (2016-2021)
3.2 Global Top Nuclease Players by Revenue (2016-2021)
3.3 Global Nuclease Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclease as of 2020)
3.4 Global Nuclease Average Price by Company (2016-2021)
3.5 Manufacturers Nuclease Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Nuclease Market Size by Type
4.1 Global Nuclease Historic Market Review by Type (2016-2021)
4.1.1 Global Nuclease Sales Market Share by Type (2016-2021)
4.1.2 Global Nuclease Revenue Market Share by Type (2016-2021)
4.1.3 Global Nuclease Price by Type (2016-2021)
4.2 Global Nuclease Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Nuclease Sales Forecast by Type (2022-2027)
4.2.2 Global Nuclease Revenue Forecast by Type (2022-2027)
4.2.3 Global Nuclease Price Forecast by Type (2022-2027)
5 Global Nuclease Market Size by Application
5.1 Global Nuclease Historic Market Review by Application (2016-2021)
5.1.1 Global Nuclease Sales Market Share by Application (2016-2021)
5.1.2 Global Nuclease Revenue Market Share by Application (2016-2021)
5.1.3 Global Nuclease Price by Application (2016-2021)
5.2 Global Nuclease Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Nuclease Sales Forecast by Application (2022-2027)
5.2.2 Global Nuclease Revenue Forecast by Application (2022-2027)
5.2.3 Global Nuclease Price Forecast by Application (2022-2027)
6 North America Nuclease Market Facts & Figures
6.1 North America Nuclease Sales by Company
6.1.1 North America Nuclease Sales by Company (2016-2021)
6.1.2 North America Nuclease Revenue by Company (2016-2021)
6.2 North America Nuclease Sales Breakdown by Type
6.2.1 North America Nuclease Sales Breakdown by Type (2016-2021)
6.2.2 North America Nuclease Sales Breakdown by Type (2022-2027)
6.3 North America Nuclease Sales Breakdown by Application
6.3.1 North America Nuclease Sales Breakdown by Application (2016-2021)
6.3.2 North America Nuclease Sales Breakdown by Application (2022-2027)
7 Europe Nuclease Market Facts & Figures
7.1 Europe Nuclease Sales by Company
7.1.1 Europe Nuclease Sales by Company (2016-2021)
7.1.2 Europe Nuclease Revenue by Company (2016-2021)
7.2 Europe Nuclease Sales Breakdown by Type
7.2.1 Europe Nuclease Sales Breakdown by Type (2016-2021)
7.2.2 Europe Nuclease Sales Breakdown by Type (2022-2027)
7.3 Europe Nuclease Sales Breakdown by Application
7.3.1 Europe 142 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 142 Sales Breakdown by Application (2022-2027)
8 China Nuclease Market Facts & Figures
8.1 China Nuclease Sales by Company
8.1.1 China Nuclease Sales by Company (2016-2021)
8.1.2 China Nuclease Revenue by Company (2016-2021)
8.2 China Nuclease Sales Breakdown by Type
8.2.1 China Nuclease Sales Breakdown by Type (2016-2021)
8.2.2 China Nuclease Sales Breakdown by Type (2022-2027)
8.3 China Nuclease Sales Breakdown by Application
8.3.1 China 313 Sales Breakdown by Application (2016-2021)
8.3.2 China 313 Sales Breakdown by Application (2022-2027)
9 Japan Nuclease Market Facts & Figures
9.1 Japan Nuclease Sales by Company
9.1.1 Japan Nuclease Sales by Company (2016-2021)
9.1.2 Japan Nuclease Revenue by Company (2016-2021)
9.2 Japan Nuclease Sales Breakdown by Type
9.2.1 Japan Nuclease Sales Breakdown by Type (2016-2021)
9.2.2 Japan Nuclease Sales Breakdown by Type (2022-2027)
9.3 Japan Nuclease Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Nuclease Market Facts & Figures
10.1 Southeast Asia Nuclease Sales by Company
10.1.1 Southeast Asia Nuclease Sales by Company (2016-2021)
10.1.2 Southeast Asia Nuclease Revenue by Company (2016-2021)
10.2 Southeast Asia Nuclease Sales Breakdown by Type
10.2.1 Southeast Asia Nuclease Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Nuclease Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Nuclease Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Nuclease Market Facts & Figures
11.1 India Nuclease Sales by Company
11.1.1 India Nuclease Sales by Company (2016-2021)
11.1.2 India Nuclease Revenue by Company (2016-2021)
11.2 India Nuclease Sales Breakdown by Type
11.2.1 India Nuclease Sales Breakdown by Type (2016-2021)
11.2.2 India Nuclease Sales Breakdown by Type (2022-2027)
11.3 India Nuclease Sales Breakdown by Application
11.3.1 India Nuclease Sales Breakdown by Application (2016-2021)
11.3.2 India Nuclease Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Nuclease Business
12.1 New England Biolabs
12.1.1 New England Biolabs Corporation Information
12.1.2 New England Biolabs Business Overview
12.1.3 New England Biolabs Nuclease Sales, Revenue and Gross Margin (2016-2021)
12.1.4 New England Biolabs Nuclease Products Offered
12.1.5 New England Biolabs Recent Development
12.2 MercK
12.2.1 MercK Corporation Information
12.2.2 MercK Business Overview
12.2.3 MercK Nuclease Sales, Revenue and Gross Margin (2016-2021)
12.2.4 MercK Nuclease Products Offered
12.2.5 MercK Recent Development
12.3 Illumina
12.3.1 Illumina Corporation Information
12.3.2 Illumina Business Overview
12.3.3 Illumina Nuclease Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Illumina Nuclease Products Offered
12.3.5 Illumina Recent Development
12.4 Thermo Fisher Scientific
12.4.1 Thermo Fisher Scientific Corporation Information
12.4.2 Thermo Fisher Scientific Business Overview
12.4.3 Thermo Fisher Scientific Nuclease Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Thermo Fisher Scientific Nuclease Products Offered
12.4.5 Thermo Fisher Scientific Recent Development
12.5 Agilent Technologies
12.5.1 Agilent Technologies Corporation Information
12.5.2 Agilent Technologies Business Overview
12.5.3 Agilent Technologies Nuclease Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Agilent Technologies Nuclease Products Offered
12.5.5 Agilent Technologies Recent Development
12.6 Cytiva
12.6.1 Cytiva Corporation Information
12.6.2 Cytiva Business Overview
12.6.3 Cytiva Nuclease Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Cytiva Nuclease Products Offered
12.6.5 Cytiva Recent Development
12.7 Roche
12.7.1 Roche Corporation Information
12.7.2 Roche Business Overview
12.7.3 Roche Nuclease Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Roche Nuclease Products Offered
12.7.5 Roche Recent Development
12.8 Takara Bio
12.8.1 Takara Bio Corporation Information
12.8.2 Takara Bio Business Overview
12.8.3 Takara Bio Nuclease Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Takara Bio Nuclease Products Offered
12.8.5 Takara Bio Recent Development
12.9 C-LEcta
12.9.1 C-LEcta Corporation Information
12.9.2 C-LEcta Business Overview
12.9.3 C-LEcta Nuclease Sales, Revenue and Gross Margin (2016-2021)
12.9.4 C-LEcta Nuclease Products Offered
12.9.5 C-LEcta Recent Development
12.10 Aldevron
12.10.1 Aldevron Corporation Information
12.10.2 Aldevron Business Overview
12.10.3 Aldevron Nuclease Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Aldevron Nuclease Products Offered
12.10.5 Aldevron Recent Development
12.11 Lucigen
12.11.1 Lucigen Corporation Information
12.11.2 Lucigen Business Overview
12.11.3 Lucigen Nuclease Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Lucigen Nuclease Products Offered
12.11.5 Lucigen Recent Development
12.12 Promega Corporation
12.12.1 Promega Corporation Corporation Information
12.12.2 Promega Corporation Business Overview
12.12.3 Promega Corporation Nuclease Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Promega Corporation Nuclease Products Offered
12.12.5 Promega Corporation Recent Development
12.13 Qiagen
12.13.1 Qiagen Corporation Information
12.13.2 Qiagen Business Overview
12.13.3 Qiagen Nuclease Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Qiagen Nuclease Products Offered
12.13.5 Qiagen Recent Development
12.14 Amicogen
12.14.1 Amicogen Corporation Information
12.14.2 Amicogen Business Overview
12.14.3 Amicogen Nuclease Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Amicogen Nuclease Products Offered
12.14.5 Amicogen Recent Development
12.15 Codexis
12.15.1 Codexis Corporation Information
12.15.2 Codexis Business Overview
12.15.3 Codexis Nuclease Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Codexis Nuclease Products Offered
12.15.5 Codexis Recent Development
12.16 BBI Solution
12.16.1 BBI Solution Corporation Information
12.16.2 BBI Solution Business Overview
12.16.3 BBI Solution Nuclease Sales, Revenue and Gross Margin (2016-2021)
12.16.4 BBI Solution Nuclease Products Offered
12.16.5 BBI Solution Recent Development
13 Nuclease Manufacturing Cost Analysis
13.1 Nuclease Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Nuclease
13.4 Nuclease Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Nuclease Distributors List
14.3 Nuclease Customers
15 Market Dynamics
15.1 Nuclease Market Trends
15.2 Nuclease Drivers
15.3 Nuclease Market Challenges
15.4 Nuclease Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Nuclease Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Nuclease Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Nuclease Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Nuclease Sales (K Units) by Region (2016-2021)
Table 5. Global Nuclease Sales Market Share by Region (2016-2021)
Table 6. Global Nuclease Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Nuclease Revenue Share by Region (2016-2021)
Table 8. Global Nuclease Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Nuclease Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Nuclease Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Nuclease Revenue Share Forecast by Region (2022-2027)
Table 12. Global Nuclease Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Nuclease Sales Share by Company (2016-2021)
Table 14. Global Nuclease Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Nuclease Revenue Share by Company (2016-2021)
Table 16. Global Nuclease by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclease as of 2020)
Table 17. Global Nuclease Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Nuclease Manufacturing Sites and Area Served
Table 19. Manufacturers Nuclease Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Nuclease Sales (K Units) by Type (2016-2021)
Table 22. Global Nuclease Sales Share by Type (2016-2021)
Table 23. Global Nuclease Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Nuclease Price (USD/Unit) by Type (2016-2021)
Table 25. Global Nuclease Sales Share by Type (2022-2027)
Table 26. Global Nuclease Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Nuclease Revenue Share by Type (2022-2027)
Table 28. Global Nuclease Price (USD/Unit) by Type (2022-2027)
Table 29. Global Nuclease Sales (K Units) by Application (2016-2021)
Table 30. Global Nuclease Sales Share by Application (2016-2021)
Table 31. Global Nuclease Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Nuclease Price (USD/Unit) by Application (2016-2021)
Table 33. Global Nuclease Sales (K Units) by Application (2022-2027)
Table 34. Global Nuclease Sales Share by Application (2022-2027)
Table 35. Global Nuclease Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Nuclease Revenue Share by Application (2022-2027)
Table 37. Global Nuclease Price (USD/Unit) by Application (2022-2027)
Table 38. North America Nuclease Sales (K Units) by Company (2016-2021)
Table 39. North America Nuclease Sales Market Share by Company (2016-2021)
Table 40. North America Nuclease Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Nuclease Revenue Market Share by Company (2016-2021)
Table 42. North America Nuclease Sales by Type (2016-2021) & (K Units)
Table 43. North America Nuclease Sales Market Share by Type (2016-2021)
Table 44. North America Nuclease Sales by Type (2022-2027) & (K Units)
Table 45. North America Nuclease Sales Market Share by Type (2022-2027)
Table 46. North America Nuclease Sales by Application (2016-2021) & (K Units)
Table 47. North America Nuclease Sales Market Share by Application (2016-2021)
Table 48. North America Nuclease Sales by Application (2022-2027) & (K Units)
Table 49. North America Nuclease Sales Market Share by Application (2022-2027)
Table 50. Europe Nuclease Sales (K Units) by Company (2016-2021)
Table 51. Europe Nuclease Sales Market Share by Company (2016-2021)
Table 52. Europe Nuclease Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Nuclease Revenue Market Share by Company (2016-2021)
Table 54. Europe Nuclease Sales by Type (2016-2021) & (K Units)
Table 55. Europe Nuclease Sales Market Share by Type (2016-2021)
Table 56. Europe Nuclease Sales by Type (2022-2027) & (K Units)
Table 57. Europe Nuclease Sales Market Share by Type (2022-2027)
Table 58. Europe Nuclease Sales by Application (2016-2021) & (K Units)
Table 59. Europe Nuclease Sales Market Share by Application (2016-2021)
Table 60. Europe Nuclease Sales by Application (2022-2027) & (K Units)
Table 61. Europe Nuclease Sales Market Share by Application (2022-2027)
Table 62. China Nuclease Sales (K Units) by Company (2016-2021)
Table 63. China Nuclease Sales Market Share by Company (2016-2021)
Table 64. China Nuclease Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Nuclease Revenue Market Share by Company (2016-2021)
Table 66. China Nuclease Sales by Type (2016-2021) & (K Units)
Table 67. China Nuclease Sales Market Share by Type (2016-2021)
Table 68. China Nuclease Sales by Type (2022-2027) & (K Units)
Table 69. China Nuclease Sales Market Share by Type (2022-2027)
Table 70. China Nuclease Sales by Application (2016-2021) & (K Units)
Table 71. China Nuclease Sales Market Share by Application (2016-2021)
Table 72. China Nuclease Sales by Application (2022-2027) & (K Units)
Table 73. China Nuclease Sales Market Share by Application (2022-2027)
Table 74. Japan Nuclease Sales (K Units) by Company (2016-2021)
Table 75. Japan Nuclease Sales Market Share by Company (2016-2021)
Table 76. Japan Nuclease Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Nuclease Revenue Market Share by Company (2016-2021)
Table 78. Japan Nuclease Sales by Type (2016-2021) & (K Units)
Table 79. Japan Nuclease Sales Market Share by Type (2016-2021)
Table 80. Japan Nuclease Sales by Type (2022-2027) & (K Units)
Table 81. Japan Nuclease Sales Market Share by Type (2022-2027)
Table 82. Japan Nuclease Sales by Application (2016-2021) & (K Units)
Table 83. Japan Nuclease Sales Market Share by Application (2016-2021)
Table 84. Japan Nuclease Sales by Application (2022-2027) & (K Units)
Table 85. Japan Nuclease Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Nuclease Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Nuclease Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Nuclease Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Nuclease Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Nuclease Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Nuclease Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Nuclease Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Nuclease Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Nuclease Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Nuclease Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Nuclease Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Nuclease Sales Market Share by Application (2022-2027)
Table 98. India Nuclease Sales (K Units) by Company (2016-2021)
Table 99. India Nuclease Sales Market Share by Company (2016-2021)
Table 100. India Nuclease Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Nuclease Revenue Market Share by Company (2016-2021)
Table 102. India Nuclease Sales by Type (2016-2021) & (K Units)
Table 103. India Nuclease Sales Market Share by Type (2016-2021)
Table 104. India Nuclease Sales by Type (2022-2027) & (K Units)
Table 105. India Nuclease Sales Market Share by Type (2022-2027)
Table 106. India Nuclease Sales by Application (2016-2021) & (K Units)
Table 107. India Nuclease Sales Market Share by Application (2016-2021)
Table 108. India Nuclease Sales by Application (2022-2027) & (K Units)
Table 109. India Nuclease Sales Market Share by Application (2022-2027)
Table 110. New England Biolabs Corporation Information
Table 111. New England Biolabs Description and Business Overview
Table 112. New England Biolabs Nuclease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. New England Biolabs Nuclease Product
Table 114. New England Biolabs Recent Development
Table 115. MercK Corporation Information
Table 116. MercK Description and Business Overview
Table 117. MercK Nuclease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. MercK Nuclease Product
Table 119. MercK Recent Development
Table 120. Illumina Corporation Information
Table 121. Illumina Description and Business Overview
Table 122. Illumina Nuclease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Illumina Nuclease Product
Table 124. Illumina Recent Development
Table 125. Thermo Fisher Scientific Corporation Information
Table 126. Thermo Fisher Scientific Description and Business Overview
Table 127. Thermo Fisher Scientific Nuclease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Thermo Fisher Scientific Nuclease Product
Table 129. Thermo Fisher Scientific Recent Development
Table 130. Agilent Technologies Corporation Information
Table 131. Agilent Technologies Description and Business Overview
Table 132. Agilent Technologies Nuclease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Agilent Technologies Nuclease Product
Table 134. Agilent Technologies Recent Development
Table 135. Cytiva Corporation Information
Table 136. Cytiva Description and Business Overview
Table 137. Cytiva Nuclease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Cytiva Nuclease Product
Table 139. Cytiva Recent Development
Table 140. Roche Corporation Information
Table 141. Roche Description and Business Overview
Table 142. Roche Nuclease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Roche Nuclease Product
Table 144. Roche Recent Development
Table 145. Takara Bio Corporation Information
Table 146. Takara Bio Nuclease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Takara Bio Description and Business Overview
Table 148. Takara Bio Nuclease Product
Table 149. Takara Bio Recent Development
Table 150. C-LEcta Corporation Information
Table 151. C-LEcta Nuclease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. C-LEcta Description and Business Overview
Table 153. C-LEcta Nuclease Product
Table 154. C-LEcta Recent Development
Table 155. Aldevron Corporation Information
Table 156. Aldevron Description and Business Overview
Table 157. Aldevron Nuclease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Aldevron Nuclease Product
Table 159. Aldevron Recent Development
Table 160. Lucigen Corporation Information
Table 161. Lucigen Description and Business Overview
Table 162. Lucigen Nuclease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Lucigen Nuclease Product
Table 164. Lucigen Recent Development
Table 165. Promega Corporation Corporation Information
Table 166. Promega Corporation Description and Business Overview
Table 167. Promega Corporation Nuclease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. Promega Corporation Nuclease Product
Table 169. Promega Corporation Recent Development
Table 170. Qiagen Corporation Information
Table 171. Qiagen Description and Business Overview
Table 172. Qiagen Nuclease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 173. Qiagen Nuclease Product
Table 174. Qiagen Recent Development
Table 175. Amicogen Corporation Information
Table 176. Amicogen Description and Business Overview
Table 177. Amicogen Nuclease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 178. Amicogen Nuclease Product
Table 179. Amicogen Recent Development
Table 180. Codexis Corporation Information
Table 181. Codexis Description and Business Overview
Table 182. Codexis Nuclease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 183. Codexis Nuclease Product
Table 184. Codexis Recent Development
Table 185. BBI Solution Corporation Information
Table 186. BBI Solution Description and Business Overview
Table 187. BBI Solution Nuclease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 188. BBI Solution Nuclease Product
Table 189. BBI Solution Recent Development
Table 190. Production Base and Market Concentration Rate of Raw Material
Table 191. Key Suppliers of Raw Materials
Table 192. Nuclease Distributors List
Table 193. Nuclease Customers List
Table 194. Nuclease Market Trends
Table 195. Nuclease Market Drivers
Table 196. Nuclease Market Challenges
Table 197. Nuclease Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Nuclease Product Picture
Figure 2. Global Nuclease Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Nuclease Sales Market Share by Application in 2021 & 2027
Figure 6. Academic & Research Institutes Examples
Figure 7. Biopharmaceutical Examples
Figure 8. Hospitals & Diagnostic Centers Examples
Figure 9. Other Examples
Figure 10. Global Nuclease Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Nuclease Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Nuclease Sales (K Units) Growth Rate (2016-2027)
Figure 13. Global Nuclease Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 14. Global Nuclease Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Nuclease Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Nuclease Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Nuclease Sales (K Units) Growth Rate (2016-2027)
Figure 18. Europe Nuclease Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Nuclease Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Nuclease Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Nuclease Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Nuclease Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Nuclease Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Nuclease Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Nuclease Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Nuclease Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Nuclease Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Nuclease Players Market Share by Revenue in Nuclease: 2016 & 2020
Figure 29. Nuclease Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Nuclease Revenue Share by Type (2016-2021)
Figure 31. Global Nuclease Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Nuclease Revenue Share by Application (2016-2021)
Figure 33. Global Nuclease Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Nuclease Sales Market Share by Type in 2020
Figure 35. North America Nuclease Sales Market Share by Application in 2020
Figure 36. Europe Nuclease Sales Market Share by Type in 2020
Figure 37. Europe Nuclease Sales Market Share by Application in 2020
Figure 38. China Nuclease Sales Market Share by Type in 2020
Figure 39. China Nuclease Sales Market Share by Application in 2020
Figure 40. Japan Nuclease Sales Market Share by Type in 2020
Figure 41. Japan Nuclease Sales Market Share by Application in 2020
Figure 42. Southeast Asia Nuclease Sales Market Share by Type in 2020
Figure 43. Southeast Asia Nuclease Sales Market Share by Application in 2020
Figure 44. India Nuclease Sales Market Share by Type in 2020
Figure 45. India Nuclease Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Nuclease
Figure 48. Manufacturing Process Analysis of Nuclease
Figure 49. Nuclease Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
バイオ医薬品ロジスティクスのグローバル市場2021 Biopharmaceutical Logistics is the logistics of Biopharmaceutical, medical and surgical supplies, and other products needed to support doctors, nurses, and other health and dental care providers. Because it’s final customers are responsible for the lives and health of their patients, medical logisti…- 真空支援生検装置のグローバル市場2021 Vacuum-assisted biopsy is a minimally invasive procedure that allows for the removal of multiple tissue samples. However, unlike core needle biopsy, which involves several separate needle insertions to acquire multiple samples, the special biopsy probe used during vacuum-assisted biopsy is inserted …
- 制限酵素のグローバル市場2021 Restriction Endonuclease is an enzyme that cuts DNA at or near specific recognition nucleotide sequences known as restriction sites. They are the enzymes that are found in the bacteria and are harvested from them for their use in research and commercial aspects. Restriction enzymes are commonly clas…
- 世界のバイオ医薬品包装市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Biopharmaceutical Packaging Market The global Biopharmaceutical Packaging market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…
- モノクローナル抗体診断試薬のグローバル市場2021 Monoclonal Antibody Diagnostic Reagents are reagents whose active ingredients are monoclonal antibodies to identify infectious agents, abnormal cells or elements of the body's response to disease. At present, in the foreign industrial developed countries the Monoclonal Antibody Diagnostic Reagents i…